HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

KFF Unveils “The Business of Health” Podcast with Chip Kahn

KFF’s new weekly podcast debuts April 2026, diving into healthcare’s financial and policy mechanics, starting with a series on AI in medicine.

By RxInsider Editorial · Apr 17, 2026 · 313 words · via KFF Health News
KFF Unveils “The Business of Health” Podcast with Chip Kahn

Image: KFF Health News

KFF Health News has launched a new weekly podcast, The Business of Health with Chip Kahn, hosted by KFF Senior Visiting Fellow Charles N. “Chip” Kahn III. In a trailer released April 15, Kahn described the show as an examination of “the business of health care” , and how the system must actually function if it’s going to serve patients. The first series turns the spotlight on artificial intelligence in health care, with guests drawn from those deploying AI tools, managing their consequences, and shaping policy around them. Kahn also holds fellowships at the American Enterprise Institute and the USC Schaeffer Center for Health Policy & Economics, and he co-chairs the international Future of Health collaborative. Credentials to spare.

The launch reflects KFF’s broader effort to connect with executive and policy audiences now rethinking the economics of care delivery. With Kahn’s long experience bridging Washington policy and provider finance, the podcast enters the field with built-in credibility. Choosing AI as the first theme isn’t accidental; it signals how analytics, automation, and regulation have begun to converge inside hospitals and benefits contracting alike. For payer and provider executives, this series could serve as an early indicator of how policymakers plan to balance innovation against cost control. Not theory. Strategy.

Episodes are expected to carry weight for investors and corporate benefits leaders following PBM reform, AI governance, and reimbursement design. If it draws senior policymakers and C‑suite guests, the show may start to shape how the industry interprets federal actions around data use, pricing mechanisms, and technology adoption. In that way, KFF seems to be treating the podcast less as a commentary platform than as an active forum where the business architecture of care policy gets mapped in real time. Then again, that’s exactly what the industry needs right now , fewer press releases, more real conversations that define where health economics go next.

Tags
theweekformat:briefingsynthesispolicyresearch
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
Rising Stars: WPP's Meghan O'Hora on the 'complex puzzle' of oncology drug marketing
The WeekFiercePharma ↗
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
Jun 3, 2026
New heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cells
The WeekFierceBiotech ↗
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
Jun 3, 2026
Cingulate’s FDA Rejection Centers on Manufacturing, Not Safety
The WeekBriefing
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…
Jun 3, 2026